Citations

Showing 10 of 108083 citations.

Therapeutic drug monitoring following crushed administration of delayed-release posaconazole tablets via enteral feeding tubes
Stevens, Ryan W. , O’Connell, Casey, Huang, Angie, Epps, Kevin , Ilges, Dan , Epps, Kevin L, Stevens, Ryan W , Ilges, Dan

Mayo Clinic

Journal of Antimicrobial Chemotherapy | December 22, 2022 | Volume: 78 | Issue: 2 | Pages: 553-555

10.1093/jac/dkac427 | PMID 36544355 Get It

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline
Fuleihan, Ghada El‐Hajj , Clines, Gregory A. , Hu, Mimi I. , Marcocci, Claudio , Murad, M. Hassan , Piggott, Thomas , Poznak, Catherine Van , Wu, Joy Y. , Drake, Matthew T. , El-Hajj Fuleihan, Ghada , Van Poznak, Catherine , Murad, M Hassan , Drake, Matthew T , Piggott, Thomas

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 22, 2022 | Volume: 108 | Issue: 3 | Pages: 507-528

10.1210/clinem/dgac621 | PMID 36545746 Get It

Abstract Background Hypercalcemia of malignancy (HCM) is the most common metabolic complication of malignancies, but its incidence may be declining due to potent chemotherapeutic agents. The high mortality associated with HCM has declined markedly due to the introduction of increasingly effective chemotherapeutic drugs. Despite the widespread availability of efficacious medications to treat HCM, evidence-based recommendations to manage this debilitating condition are lacking. Objective To develop guidelines for the treatment of adults with HCM. Methods A multidisciplinary panel of clinical experts, together with experts in systematic literature review, identified and prioritized 8 clinical questions related to the treatment of HCM in adult patients. The systematic reviews (SRs) queried electronic databases for studies relevant to the selected questions. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make recommendations. An independent SR was conducted in parallel to assess patients' and physicians' values and preferences, costs, resources needed, acceptability, feasibility, equity, and other domains relevant to the Evidence-to-Decision framework as well as to enable judgements and recommendations. Results The panel recommends (strong recommendation) in adults with HCM treatment with denosumab (Dmab) or an intravenous (IV) bisphosphonate (BP). The following recommendations were based on low certainty of the evidence. The panel suggests (conditional recommendation) (1) in adults with HCM, the use of Dmab rather than an IV BP; (2) in adults with severe HCM, a combination of calcitonin and an IV BP or Dmab therapy as initial treatment; and (3) in adults with refractory/recurrent HCM despite treatment with BP, the use of Dmab. The panel suggests (conditional recommendation) the addition of an IV BP or Dmab in adult patients with hypercalcemia due to tumors associated with high calcitriol levels who are already receiving glucocorticoid therapy but continue to have severe or symptomatic HCM. The panel suggests (conditional recommendation) in adult patients with hypercalcemia due to parathyroid carcinoma, treatment with either a calcimimetic or an antiresorptive (IV BP or Dmab). The panel judges the treatments as probably accessible and feasible for most recommendations but noted variability in costs, resources required, and their impact on equity. Conclusions The panel's recommendations are based on currently available evidence considering the most important outcomes in HCM to patients and key stakeholders. Treatment of the primary malignancy is instrumental for controlling hypercalcemia and preventing its recurrence. The recommendations provide a framework for the medical management of adults with HCM and incorporate important decisional and contextual factors. The guidelines underscore current knowledge gaps that can be used to establish future research agendas.
Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia
Badar, Talha , Litzow, Mark R. , Shallis, Rory M. , Patel, Anand , Saliba, Antoine N. , Burkart, Madelyn , Stahl, Maximilian , Correia, Guilherme Sacchi de Camargo, Murthy, Guru Subramanian Guru , Bradshaw, Danielle , Kota, Vamsi , Dinner, Shira, Palmisiano, Neil , Kali, Aref Al, Saliba, Antoine N. , Bewersdorf, Jan P , De Camargo Correia, Guilherme Sacchi, Murthy, Guru , Abaza, Yasmin , Kota, Vamsi , Al Kali, Aref, Patel, Anand , Saliba, Antoine N , Badar, Talha , Saliba, Antoine N , Burkart, Madelyn , Bewersdorf, Jan Philipp , Abaza, Yasmin , DuVall, Adam , Goldberg, Aaron D. , Atallah, Ehab

Mayo Clinic

Cancer | December 22, 2022 | Volume: 129 | Issue: 6 | Pages: 934-945

10.1002/cncr.34604 | PMID 36545710 Get It

AbstractBackgroundAlthough the clinical outcomes of patients with TP53‐mutated acute myeloid leukemia (AML) are dismal, subsets of patients eligible for curative‐intent therapies may fare better. Because racial disparities are known to affect outcome in hematologic malignancies, the authors sought to explore disparities among patients with TP53‐mutated AML.MethodsA multicenter, retrospective study was conducted in a cohort of 340 patients who had TP53‐mutated AML (275 non‐Hispanic White [NHW] and 65 non‐Hispanic Black [NHB]) to analyze differences in treatment and outcome among NHW and NHB patients.ResultsThe median patient age was comparable between NHW and NHB patients (p = .76). A higher proportion of NHB patients had therapy‐related AML (31% vs. 20%; p = .08) and had co‐mutations (74% vs. 61%; p = .06). A higher proportion of NHW patients received intensive chemotherapy compared with NHB patients (47% vs. 31%; p = .02). Conversely, a higher proportion of NHB patients received low‐intensity chemotherapy (9% vs. 5.5%; p = .02) or best supportive care (22% vs. 7%; p < .001). The complete response rate (including complete responses with or without complete count recovery) was 31% versus 24.5% (p = .39) in NHW and NHB patients, respectively. Only 5% of NHB patients received allogeneic stem cell transplantation compared with 15.5% of NHW patients (p = .02). The proportion of patients who were event‐free (18.5% vs. 8.5%; p = .49) or who remained alive (24.9% vs. 8.3%; p = .13) at 18 months was numerically higher in NHW versus NHB patients, respectively, but was not statistically significant.ConclusionsThe current study highlights disparities between NHW and NHB patients with TP53‐mutated AML. Efforts are warranted to eliminate treatment disparities in minority populations.
Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance
Laughlin, Brady S. , Yu, Nathan Y. , Lo, Stephanie, Duan, Jingwei , Welchel, Zachary James, Tinnon, Katie, Beckett, Mason, Wong, William W. , Keole, Sameer R., Rwigema, Jean‐Claude M. , Vargas, Carlos , Welchel, Zachary, Schild, Steven E. , Duan, Jingwei , Laughlin, Brady S , Rong, Yi

Mayo Clinic

Cancers | December 22, 2022 | Volume: 15 | Issue: 1 | Pages: 40

10.3390/cancers15010040 | PMID 36612040 Get It

Purpose: Planning target volume (PTV) expansion for post-prostatectomy radiotherapy is typically ≥5 mm. Recent clinical trials have proved the feasibility of a reduced margin of 2–3 mm for treatments on MRI-linac. We aim to study the minimum PTV margin needed using iterative cone-beam CT (iCBCT) as image guidance on conventional linacs. Materials/Methods: Fourteen patients who received post-prostatectomy irradiation (8 with an endorectal balloon and 6 without a balloon) were included in this study. Treatment was delivered with volumetric modulated radiation therapy (VMAT). Fractional dose delivery was evaluated in 165 treatment fractions. The bladder, rectal wall, femoral heads, and prostate bed clinical tumor volume (CTV) were contoured and verified on daily iCBCT. PTV margins (0 mm, 2 mm, and 4 mm) were evaluated on daily iCBCT. CTV coverage and OAR dose parameters were assessed with each PTV margin. Results: CTV D100% was underdosed with a 0 mm margin in 32% of fractions in comparison with 2 mm (6%) and 4 mm (6%) PTV margin (p ≤ 0.001). CTV D95% > 95% was met in 93–94% fractions for all PTV expansions. CTV D95% > 95% was achieved in more patients with an endorectal balloon than those without: 0 mm—90/91 (99%) vs. 63/74 (85%); 2 mm—90/91 (99%) vs. 65/75 (87%); 4 mm—90/90 (100%) vs. 63/73 (86%). There was no difference in absolute median change in CTV D95% (0.32%) for 0-, 2-, and 4 mm margins. The maximum dose remained under 108% for 100% (0 mm), 97% (2 mm), and 98% (4 mm) of images. Rectal wall maximum dose remained under 108% for 100% (0 mm), 100% (2 mm), and 98% (4 mm) of images. Conclusions: With high-quality iCBCT image guidance, PTV margin accounting for inter-fractional uncertainties can be safely reduced for post-prostatectomy radiotherapy. For fractionated radiotherapy, an isotropic expansion of 2 mm and 4 mm may be considered for margin expansion with and without the endorectal balloon. Future application for margin reduction needs to be further evaluated and considered with the advent of shorter post-prostatectomy radiation courses.
Pain Control and Satisfaction With Peripheral Nerve Blocks for Upper Extremity Surgery
Wu, Caroline M., Gary, Cyril S., Karim, Kristin E. , Sanghavi, Kavya K. , Murphy, Michael S, Hobelmann, J. Todd, Giladi, Aviram M.

Mayo Clinic

HAND | December 21, 2022 | Volume: 19 | Issue: 4 | Pages: 555-561

10.1177/15589447221141482 | PMID 36544240 Get It

Background: Regional anesthesia (“block”) is an important component of upper extremity (UE) surgery pain control. However, little is known about patient experience related to perioperative opioid use. This study assessed patient-reported pain control and satisfaction with UE blocks and evaluated how opioid consumption impacted these outcomes before the block “wore off.” Methods: A postoperative phone survey was administered to patients who underwent outpatient UE surgery at a surgery center for more than 16 months. It assessed pain scores (scale 1-10), satisfaction with block duration (scale 1-5), duration until return of UE function, and opioid consumption. Analyses used Mann-Whitney U tests, Fisher exact tests, and bivariate and multivariable linear and ordered logistic regressions to understand relationships between opioid use and outcomes. Results: A total of 509 patients (61%) completed the survey, and 441 (88%) were satisfied with block duration. Initial and final pain scores were significantly higher in patients who took opioids prior to the block wearing off (6 and 4.5, P = .04 and 3.5 and 2, P = .002, respectively). Although satisfaction with block duration was not different in group comparisons (ie, patients who premedicated vs those who did not), in a multivariable analysis, patients who premedicated with opioids had 78% increased odds of reporting the highest level of satisfaction compared with the lower 4 levels ( P = .03). Conclusions: Upper extremity blocks are associated with high overall patient satisfaction and postsurgical pain control. Premedicating before the block wears off may increase patient satisfaction with block duration even if pain is not notably impacted.
Small Cell Transformation in a Patient With RET Fusion–Positive Lung Adenocarcinoma on Pralsetinib
Dimou, Anastasios , Lo, Ying‐Chun , Merrell, Kenneth W. , Halling, Kevin C. , Mansfield, Aaron S. , Mansfield, Aaron S , Merrell, Kenneth W , Lo, Ying-Chun , Dimou, Anastasios

Mayo Clinic

JCO Precision Oncology | December 21, 2022 | Volume: No volume available | Issue: 6 | Pages: No page available

10.1200/po.22.00478 | PMID 36542817 Get It

Transcanal Endoscopic Repair of an Anterior Epitympanic Encephalocele
Kocharyan, Arminé , Daher, Ghazal S. , Manzoor, Nauman F. , Johnson, Benjamin R. G.

Mayo Clinic

Otology & Neurotology | December 21, 2022 | Volume: 44 | Issue: 2 | Pages: e117-e117

10.1097/mao.0000000000003789 | PMID 36543193 Get It

Safe management of carotid body tumor resection without preoperative embolization: an Ecuadorian high-altitude cities experience
Solis-Pazmino, Paola , Tite, Belen, García, Mikaela, Godoy, Richard, Rocha, Carla , Ponce, Oscar J. , Dy, Benzon M. , García, Cristhian, Solís-Pazmiño, Paola , Ponce, Oscar Josue , Pilatuna, Eduardo A , Godoy, Richard

Mayo Clinic

Journal of Surgical Case Reports | December 21, 2022 | Volume: 2022 | Issue: 12 | Pages: No page available

10.1093/jscr/rjac598 | PMID 36570551 Get It

Abstract Carotid body tumors (CBTs) are a neoplasm that affects the carotid glomus. This study aims to improve the management of CBTs in Ecuador. This single-center, retrospective observational study was conducted at the Instituto de la Tiroides y Enfermedades de Cabeza y Cuello (ITECC). We included adults with CBTs, between January 2019 and August 2022. A total of 15 patients with CBTs were included. All patients were females living at high altitudes (&gt;2500 m). In the Shamblin classification, 12 tumors were type II, and 3 were type III. Complete tumor resection was performed in all patients without pre-operative embolization. All patients had benign CBTs with a mean follow-up of 17, 73 months. In a time when the medical cost is high mainly in low-income countries such as Ecuador, further investigation should be undertaken in the form of randomized prospective trials to answer who would benefit from the pre-TAE procedure.
Technical note: Four‐year experience with utilization of DICOM metadata analytics in clinical digital radiography practice
Long, Zaiyang , Walz‐Flannigan, Alisa , Littrell, Laurel A. , Schueler, Beth A.

Mayo Clinic

Medical Physics | December 21, 2022 | Volume: 50 | Issue: 2 | Pages: 831-836

10.1002/mp.16170 | PMID 36542418 Get It

AbstractBackgroundDigital radiography (DR) still presents many challenges and could have complex imaging acquisition and processing patterns in a clinical practice hindering quality standardization.PurposeThis technical note aims to report the 4‐year experience with utilizing a custom DICOM metadata analytics program in clinical DR at a large institution.MethodsThirty‐eight DR systems of three vendors at multiple locations were configured to automatically send clinical DICOM images to a DICOM receiver. A suite of custom MATLAB programs was established to extract and store public and private header data weekly. Specific use cases are provided for systematic image acquisition investigation, image processing harmonization, exposure index (EI) longitudinal monitoring and EI target optimization.ResultsFor systematic acquisition investigation, an example of adult lumbar spine exam analysis was provided with statistics on manual acquisition versus the use of automatic exposure control (AEC, including AEC dose level, active cell, and backup timer), grid usage, and collimation for various projections. For processing harmonization, up to 12.6% of protocols were revealed to have processing parameter differences in an example of a mobile radiography fleet. In addition, inconsistent use of a post‐acquisition image size function was also demonstrated, which resulted in anatomy size display variations. Bimonthly monitoring of median EI values showed expected trends, including changes after an AEC dose level adjustment for adult posterior‐anterior chest imaging on a scanner system. An example of adult axillary shoulder EI target refinement was shared using the median value, eμ, based on the lognormal EI data distribution after parsing down to acquisitions with appropriate techniques.ConclusionsThis analytics program enables systematic analysis of image acquisition and processing details. The information provides invaluable insights into real practice patterns, which can support data‐driven quality standardization and optimization.